Transcriptomics based prediction of survival and response to therapy in malignant mesothelioma
Nishanth Ulhas Nair(National Cancer Institute), Raffit Hassan(National Cancer Institute), Alexandra Lebensohn(National Institutes of Health), Jun S. Wei(National Cancer Institute), Manjistha Sengupta(National Institutes of Health), Joo Sang Lee(National Institutes of Health), Leandro C. Hermida(National Cancer Institute), Javed Khan(National Institutes of Health), Qun Jiang(Center for Cancer Research), Chimene Kesserwan(National Cancer Institute), Jingli Zhang(Queensland University of Technology), Eytan Ruppin(National Institutes of Health), Betsy Morrow(National Institutes of Health), Idrees Mian(National Institutes of Health), Vikram Misra(Center for Cancer Research)
Cited by 1
Related Papers
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
|Nature Medicine|2018|813
DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
|PLoS ONE|2012|278
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
|Genetics in Medicine|2017|219